September 15th 2021
Although immunotherapy has provided patients with small cell lung cancer with a “light at the end of the tunnel,” an expert from City of Hope argues more research is needed.
September 8th 2021
Increased use of radiation in lung cancer treatment may be a result of discoveries in research and improved spreading of information on this technology.
September 2nd 2021
More focus is needed on increasing lung cancer screening for patients, especially in those who are eligible for it according to their smoking history.
August 31st 2021
New advancements in the staging process for lung cancer are leading to faster recoveries and better diagnoses.
August 30th 2021
Clinical trials are an invaluable resource to the cancer community, as they continually advance treatment options for patients. An expert explains how they work and what patients should know.
August 27th 2021
Treating lung cancer is more precise than ever, thanks to biomarker testing, which gives clinicians a better understanding of individual’s tumors.
August 14th 2021
View the full CURE Educated Patient Lung Cancer Summit on demand.
April 10th 2021
Take a look back at CURE®’s Educated Patient® Lung Cancer Summit with this roundup of stories that highlight what was discussed at this half-day virtual event.
March 15th 2021
In the field of lung cancer, a number of current studies evaluating the efficacy of adoptive cellular therapies may one day offer patients with non-small cell lung cancer a “high risk, high reward” treatment option, according to Dr. Ben Creelan of the Moffitt Cancer Center.
March 12th 2021
As the population ages, the incidence of older adults being diagnosed with lung cancer is increasing, though data on how to specifically treat this population are lacking.
March 10th 2021
An expert discusses ways that small cell lung cancer is diagnosed, how to treat it and how to pivot if the disease spreads or recurs. He also focuses on efforts in the clinical trial space to potentially treat patients more effectively.
March 6th 2021
January 28th 2021
Biomarkers play an important role in treatment decisions of many tumors, but in lung cancer they are a deciding factor between which immunotherapy is the best option.
January 2nd 2021
In an interview with CURE®, Dr. Wade T. Iams discussed small cell lung cancer, a subtype of lung cancer that starts from neuroendocrine cells in the lung, how different stages are treated and the potential benefits of having a treatment team to communicate with every step of the way.
December 22nd 2020
Dr. Sally J. York goes over the types of immunotherapy-related side effects, and what patients with lung cancer and their caregivers should look out for.
Educated Patient® MPN Summit Approach to Diagnosing & Assessing Symptoms Presentation: May 7, 2022
An Oncology Nurse Was a 'Treasure' for a Patient and His Family
A Cancer Nurse Changes the Lives of Patients
Oncology Teamwork With a Personal Touch